A new trading data show Hims & Hers Health Inc. (HIMS) is showing positive returns.

Hims & Hers Health Inc. (NYSE: HIMS) stock jumped 0.48% on Monday to $6.34 against a previous-day closing price of $6.31. With 1.99 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.03 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $6.43 whereas the lowest price it dropped to was $6.23. The 52-week range on HIMS shows that it touched its highest point at $12.34 and its lowest point at $4.01 during that stretch. It currently has a 1-year price target of $12.45. Beta for the stock currently stands at 0.53.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HIMS was down-trending over the past week, with a drop of -2.91%, but this was down by -8.38% over a month. Three-month performance dropped to -26.71% while six-month performance fell -34.91%. The stock gained 5.14% in the past year, while it has lost -1.09% so far this year. A look at the trailing 12-month EPS for HIMS yields -0.23 with Next year EPS estimates of -0.06. For the next quarter, that number is -0.03. This implies an EPS growth rate of 44.30% for this year and 57.10% for next year.

Float and Shares Shorts:

At present, 208.42 million HIMS shares are outstanding with a float of 172.76 million shares on hand for trading. On Aug 30, 2023, short shares totaled 16.65 million, which was 7.89% higher than short shares on Jul 30, 2023. In addition to Mr. Andrew Dudum as the firm’s Co-Founder, Chairman & CEO, Mr. Yemi Okupe serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 63.05% of HIMS’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 35.88% of HIMS, in contrast to 28.11% held by mutual funds. Shares owned by individuals account for 19.19%. As the largest shareholder in HIMS with 6.59% of the stake, The Vanguard Group, Inc. holds 13,347,513 shares worth 13,347,513. A second-largest stockholder of HIMS, BlackRock Fund Advisors, holds 8,135,906 shares, controlling over 4.01% of the firm’s shares. Marshall Wace LLP is the third largest shareholder in HIMS, holding 5,875,867 shares or 2.90% stake. With a 2.23% stake in HIMS, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 4,519,954 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 1.81% of HIMS stock, is the second-largest Mutual Fund holder. It holds 3,666,033 shares valued at 24.6 million. iShares Russell 2000 ETF holds 1.35% of the stake in HIMS, owning 2,733,134 shares worth 18.34 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, HIMS reported revenue of $113.56M and operating income of -$20.19M. The EBITDA in the recently reported quarter was -$18.49M and diluted EPS was -$0.10.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HIMS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HIMS analysts setting a high price target of $18.00 and a low target of $8.00, the average target price over the next 12 months is $12.30. Based on these targets, HIMS could surge 183.91% to reach the target high and rise by 26.18% to reach the target low. Reaching the average price target will result in a growth of 94.01% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded HIMS stock several times over the past three months with 8 Buys and 14 Sells. In these transactions, 231,579 shares were bought while 298,124 shares were sold. The number of buy transactions has increased to 78 while that of sell transactions has risen to 102 over the past year. The total number of shares bought during that period was 6,388,993 while 16,039,186 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *